Trials / Completed
CompletedNCT04951310
COVID-19 Vaccinations With a Sweepstakes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,827,656 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To reach herd immunity for COVID-19, experts estimate that 70% of the population will need to be vaccinated. However, vaccination rates have begun to slow down in the United States. The investigators will partner with Philadelphia to launch a COVID-19 vaccination sweepstakes, in which residents will be eligible to win if they have received at least one dose of the COVID-19 vaccine prior to a given drawing. Drawings will be held every two weeks; multiple prizes of various sizes will be awarded in each drawing. Half of the prizes in each size category in each drawing will be awarded to residents of a zip code that is randomly selected from a pre-defined list of under-vaccinated zip codes (this zip code will be announced at the start of each 2-week drawing period), the other half will be awarded to residents outside of that selected zip code. The investigators will analyze vaccination rates in Philadelphia as compared with neighboring regions before, during, and after the specified time period, as well as analyze vaccination rates in the three selected zip codes compared to the other zip codes that could have been targeted (the residual set of under-vaccinated zip codes) to determine the effectiveness of the sweepstakes at encouraging vaccinations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Philly Vax Sweepstakes | The "Philly Vax Sweepstakes" is a citywide sweepstakes designed to motivate Philadelphians to get vaccinated against COVID-19. A total of 36 vaccinated Philadelphians will win among three cash prize packages, distributed from the total cash pool. These 36 will be chosen over three drawings, with 12 residents chosen in each drawing. |
Timeline
- Start date
- 2021-06-07
- Primary completion
- 2021-08-14
- Completion
- 2021-08-14
- First posted
- 2021-07-06
- Last updated
- 2025-02-03
- Results posted
- 2025-02-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04951310. Inclusion in this directory is not an endorsement.